Green, matcha, and black tea: Effective weapons against Omicron subvariants, research reveals

FHS
October 5, 2023
12:07 pm

The efficacy of tea and its catechins in deactivating the Omicron subvariant.

Bain-backed Cardurion raises $260M to fund ex-Imara drug, buy more cardio assets

Cardurion Pharmaceuticals is going shopping for more cardio drug candidates. The Burlington, MA-based biotech, which launched in 2017 with a Sign up to read this

July 17, 2024

Researchers pioneer a novel treatment for the most common autoimmune encephalitis

Researchers at DZNE and Charité – Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.

November 3, 2023

Merck’s $3B return to eye disease; J&J’s $1.25B tuck-in; Keytruda challenger steals #ASCO24 show; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.